Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.
Saved in:
| Title: | Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study. |
|---|---|
| Authors: | Siddiqi, Zaeem A.1 (AUTHOR) zsiddiqi@ualberta.ca, Nowak, Richard J.2 (AUTHOR), Mozaffar, Tahseen3 (AUTHOR), O'Brien, Fanny4 (AUTHOR), Yountz, Marcus4 (AUTHOR), Patti, Francesco5 (AUTHOR), Mazia, Claudio Gabriel (AUTHOR), Wilken, Miguel (AUTHOR), Barroso, Fabio (AUTHOR), Saba, Juliet (AUTHOR), Rugiero, Marcelo (AUTHOR), Bettini, Mariela (AUTHOR), Chaves, Marcelo (AUTHOR), Vidal, Gonzalo (AUTHOR), Garcia, Alejandra Dalila (AUTHOR), De Bleecker, Jan (AUTHOR), Van den Abeele, Guy (AUTHOR), de Koning, Kathy (AUTHOR), De Mey, Katrien (AUTHOR), Mercelis, Rudy (AUTHOR) |
| Source: | Muscle & Nerve. Dec2021, Vol. 64 Issue 6, p662-669. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
